After years of shortages, Merck announces plans for a new factory for an old lifesaving drug
Four years after Sanofi left them as a popular bladder cancer drug’s only producer, Merck is investing in a new facility that could help ameliorate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
